February 03, 2012 – News Bytes

R&D Trends

ACTO deems Russian 2011 clinical trials market “adequate”

After gathering and analyzing data, the Association of Clinical Trials Organizations (ACTO) has concluded that the 2010 crisis brought on by Russia’s new regulations and the transfer of approval authority from Roszdravnadzor to the Health Ministry has been resolved.

CWWeekly

January 30

President's bioethics commission recommends development of a federal research database

Quintiles grows presence in biomarker sector, buys controlling share in startup Oxford Cancer Biomarkers

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs